Segmed: Medical Imaging Data Company Raises $10
Segmed – a leader in providing real-world imaging data for health innovation – announced it has raised a $10.4 million Series A funding round. This oversubscribed round was led by iGan Partners and Advocate Health, with participation from Castellan Group, Engine Health Capital, Bold Brain Ventures, Fox Chase Cancer Center, and existing investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A funding round follows financing by Flashpoint Growth Debt Fund received in 2023.
Since Segmed’s launch, it has been committed to unlocking cohorts of imaging data to support AI development and further clinical research. Segmed will use the new funding to further expand its footprint in the healthcare AI space as well as to bring medical imaging to the biopharmaceutical and life science world.
The company’s data network of leading healthcare providers enables innovators to get access to heterogeneous and diverse de-identified imaging data that can be linked with other data types. And the company’s technology enables clients to access, de-identify, standardize, and build cohorts of medical imaging data within their own environment.
KEY QUOTES:
“We are excited to partner with such a select group of health systems and healthcare technology investors to support Segmed as they continue to disrupt the healthcare industry with their innovative approach to real-world imaging data. Segmed’s platform has the potential to drive significant improvements in patient care and healthcare outcomes, and iGan stands ready to continue to support their dynamic growth and the significant impact they are poised to make on healthcare technology going forward.”
– Sam Ifergan, managing partner at iGan Partners
“Advocate Health is an industry leader in utilizing innovation to serve the health needs of individuals, families and communities. We’re driven to advance the science of medicine. To that end, our team is dedicated to developing the most comprehensive provider-based research data set in the country. We look forward to supporting Segmed in the shared goal of unlocking imaging data to accelerate medical research.”
– Emilie McKenna, managing director of strategic development and investment at Advocate Health
“We founded Segmed five years ago to improve patient outcomes by revolutionizing medical imaging research. We are thrilled to have the continued support from investors like iGan Partners and Y Combinator, as well as the addition of clinical powerhouses like Advocate Health and Fox Chase Cancer Center. Their expertise and experience will be invaluable as we continue to develop cutting-edge solutions for the future.”
“Segmed deeply appreciates the support and confidence demonstrated by these significant investments and strategic partnerships to reshape the landscape of medical imaging utilization, ultimately advancing health care.”
– Martin Willemink, CEO and co-founder at Segmed
